...
RNAAvidity Biosciences, Inc.
$72.60
Financials
WATCHLIST
Analysis updated: Jan 16, 2026

Investment Thesis

RNA broke out 2 month(s) ago at $70.00, but has stalled (+4%). Wait for fresh momentum or new base. Set a price alert and revisit when conditions improve.

Already broke out - entry point missed

Key Takeaways

Earnings Momentum

-1%
Q4'24
$-0.80
-14%
Q1'25
$-0.90
-83%
Q2'25
$-1.21
-95%
Q3'25
$-1.27
Earnings Declining

Price Structure

Aligned Uptrend
Price
$72.60
✓
→
50 DMA
$71.51
✓
→
100 DMA
$60.16
✓
→
150 DMA
$52.01
✓
→
200 DMA
$46.46
Alignment Score: 4/4✓ Confirmed Uptrend

RNA Price Chart

Loading chart...

50 DMA150 DMA200 DMA

Why Not BUY Yet?

EPS Growth
-95%→>25% Qtr YoY
RSI (14)
75 (ELEVATED)→<70 for safe entry

What Would Change Our Mind?

To turn bullish on RNA, we need:

Twin Engines Dashboard

Technical Health

RS Rating
92/99
Top 8% ✓
Trend
Aligned Uptrend
Above 200 DMA
RSI (14)
75
ELEVATED
VCP Setup
HOT
Score: 7/9
Volume
1.2M
-52% vs avg
From Entry
+3.7%
$70.00

Fundamental Horsepower

EPS Qtr YoY
-95%
Declining
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
+434%
Accelerating
F-Score
5/9
Piotroski Quality
ROE
-33%
Return on Equity
EPS Rank
25/99
Percentile

Trade Plan

Stalled Breakout

Broke out 2 months ago at $70.00 — up modestly (+4%) from entry.

Breakout has stalled. Wait for new momentum or a fresh base pattern to develop.

Breakout Date2025-10-2781 days ago
Entry Was$70.00Breakout price
Gain Since+4%From entry
Reclaim$72.0621 EMA support

If/Then Playbook

IF: Deep pullback to 50 DMA or 21 EMA
THEN: Consider adding if holds support (original entry was $70.00)
IF: New base forms after 3-6 week consolidation
THEN: Re-evaluate for fresh entry point
IF: Price drops >25% from highs
THEN: Watch for Stage 3 top formation
IF: Next earnings shows >25% EPS growth
THEN: Upgrade conviction level
IF: RS Rating drops below 75
THEN: Remove from priority watch

Key Price Levels

Resistance

  • 52W High$72.70+0.1%
  • Pivot$72.70+0.1%
Current$72.60

Support

  • 20 DMA$72.24-0.5%
  • 50 DMA$71.51-1.5%
  • 200 DMA$46.46-36.0%

More RNA Analysis

Fundamental Analysis →Intrinsic Value →Total Return Calculator →

Related Technical Analysis

Compare technical setups for similar stocks:

Frequently Asked Questions

Is RNA stock a buy now?

RNA broke out 2 month(s) ago at $70.00, but has stalled (+4%). Wait for fresh momentum or new base. Set a price alert and revisit when conditions improve.

What is the buy point for RNA?

RNA broke out at $70.00 2 month(s) ago but has stalled (+4%). Wait for fresh momentum or new base pattern.

What is RNA's RS Rating?

RNA has an RS Rating of 92/99, meaning it's in the Top 8% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.

Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.